What is Advansta?
Advansta is a specialized provider of protein characterization solutions, offering a comprehensive suite of products including western blotting reagents, antibodies, and buffers. The company serves life science researchers by facilitating custom protein analysis and providing support across various experimental design phases. Advansta's offerings are designed to improve research efficiency and accuracy, with tools supporting chemiluminescent and fluorescent western blotting, ELISA, and sample preparation.
How much funding has Advansta raised?
Advansta has raised a total of $149K across 1 funding round:
Debt
$149K
Debt (2021): $149K with participation from PPP
Key Investors in Advansta
PPP
Public-Private Partnership
What's next for Advansta?
The recent strategic investment, within the context of Advansta's large-scale late-stage funding, suggests a focus on scaling operations, expanding market reach, or further developing its innovative protein characterization technologies. This capital infusion is likely to accelerate Advansta's growth trajectory and solidify its competitive advantage in serving the demanding needs of the life sciences research community.
See full Advansta company page
